The Simplexa COVID-19 Direct kit allows for fast results directly from BAL, nasal swab, nasal wash/aspirate, nasopharyngeal swab and saliva specimens, eliminating traditional RNA extraction steps. The assay has demonstrated excellent clinical agreement and turnaround time, allowing for optimal allocation of critical resources and effective patient management decision making.
